Table 1.
“Normal” Kidneys | “Abnormal” Kidneys | Entire Group | |
---|---|---|---|
n | 21 | 29 | 50 |
Men/women | 9/12 | 13/16 | 22/28 |
Age (yr) | 69.1 ± 2.9 | 68.8 ± 2.2 | 69 ± 1.8 ± 12.5 |
Creatinine (mg/dl) | 1.48 ± 0.15 | 1.87 ± 0.15 | 1.71 ± 0.11 |
Renal artery stenosis > 70% | 10 | 19 | 29 |
Estimated GFR (total) ml/min/1.73 m2 | 49 ± 3.4 | 38.3 ± 3.4** | 43 ± 2.5 |
BOLD MR | |||
Cortex-basal R2* | 22.2 ± 2.8 | 16.7 ± 12.8** | 19.0 ± 14 |
Post-furosemide R2* | 19.1 ± 2.3 | 17.3 ± 1.7 | 18.1 ± 1.4 |
Delta R2* (%) | 30.9 ± 9 (11.3 ± 3.1%) | −6 ± 6 (−1.3 ± 2.4%)* | 9.6 ± 5 (3.9 ± 2.1%) |
Medulla-basal R2* | 24.9 ± 3.8 | 16.9 ± 1.3** | 20.3 ± 1.8 |
Post-furosemide | 19.9 ± 3.2 | 17.3 ± 1.7 | 18.4 ± 1.7 |
Delta R2* (%) | 49.5 ± 9 (20.3 ± 2.4%) | −3.6 ± 6 (0.2 ± 3.4%)* | 18.7 ± 6 |
P < 0.05,
P < 0.01 versus “normal” kidneys.